Viewing Study NCT02132260


Ignite Creation Date: 2025-12-25 @ 2:17 AM
Ignite Modification Date: 2026-03-11 @ 10:29 PM
Study NCT ID: NCT02132260
Status: COMPLETED
Last Update Posted: 2017-05-09
First Post: 2014-05-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluate the Safety and Efficacy of Naftifine Hydrochloride Cream 2% and Naftin® Cream 2% in Patients With Tinea Pedis
Sponsor: Sun Pharmaceutical Industries, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module